1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow 60P Australia Pty Ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Evaluation of the Safety and Efficacy of Randomized Placebo Versus the 8-aminoquinoline Tafenoquine for Early Symptom Resolution in Patients With Mild to Moderate COVID 19 Disease and Low Risk of Disease Progression Tafenoquine Oral Tablet, Placebo - COVID 19 Disease, Mild to Moderate COVID 19 Disease | Phase 2 | Unknown | 60P Australia Pty Ltd | 148 | 2023-08-01 | 2023-07-17 |
tafenoquine (1)
PMID 30519584, PMID 32382733, PMID 33333292, PMID 33820486, PMID 35101449, PMID 35668841, PMID 35713893, PMID 9598455